160
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Clinical effects of “pioglitazone”, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trialx1

, , , , &
Pages 208-214 | Received 16 Mar 2014, Accepted 28 May 2014, Published online: 01 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Guizhen Chang, Jin Wang, Jingxin Song, Zhilong Zhang & Litao Zhang. (2020) Efficacy and safety of pioglitazone for treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. Journal of Dermatological Treatment 31:7, pages 680-686.
Read now
Maryam Ghiasi, Sahar Ebrahimi, Vahide Lajevardi, Mohammad Taraz & Arghavan Azizpour. (2019) Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a Double Blinded Randomized Controlled Trial. Journal of Dermatological Treatment 30:7, pages 664-667.
Read now

Articles from other publishers (15)

Mateusz Matwiejuk, Hanna Mysliwiec, Olivia Jakubowicz-Zalewska, Adrian Chabowski & Iwona Flisiak. (2023) Effects of Hypolipidemic Drugs on Psoriasis. Metabolites 13:4, pages 493.
Crossref
Vladimir V. Sobolev, Ekaterina Tchepourina, Irina M. Korsunskaya, Natalia A. Geppe, Svetlana N. Chebysheva, Anna G. Soboleva & Alexandre Mezentsev. (2022) The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells. International Journal of Molecular Sciences 23:17, pages 9708.
Crossref
Xiran Lin, Xianmin Meng, Zhiqi Song & Jingrong Lin. (2022) Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry. Molecular and Cellular Biochemistry 477:7, pages 1905-1920.
Crossref
Jessica E. Ferguson, Edward W. Seger, Jacob White & Amy McMichael. (2022) Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review. Archives of Dermatological Research 315:1, pages 41-50.
Crossref
I.V. Pankiv. (2021) Insulin resistance in patients with psoriasis. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 17:7, pages 570-574.
Crossref
Shekhar Neema, Sunmeet Sandhu, Ankan Gupta, Soumya Jagadeesan & Biju Vasudevan. (2021) Unconventional treatment options in psoriasis: A review. Indian Journal of Dermatology, Venereology and Leprology 88, pages 137-143.
Crossref
Mei-Xian Zhang, Bo-Yuan Zheng, Hai-Xiao Chen & Ching-Wen Chien. (2021) Clinical effects of antidiabetic drugs on psoriasis: The perspective of evidence-based medicine. World Journal of Diabetes 12:8, pages 1141-1145.
Crossref
Ana Maria Alexandra Stanescu, Anca Angela Simionescu, Mira Florea & Camelia Cristina Diaconu. (2021) Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review. Journal of Personalized Medicine 11:4, pages 251.
Crossref
Ching‐Chi Chi, Chin‐Yu Lee, Chia‐Yu Liu, Shu‐Hui Wang, Felice Tien O’Donnell & Tao‐Hsin Tung. (2020) Effects of antidiabetic drugs on psoriasis: A meta‐analysis. European Journal of Clinical Investigation 51:2.
Crossref
Mirjam J. Schaap, Marieke E.C. van Winden, Marieke M.B. Seyger, Elke M.G.J. de Jong & Satish F.K. Lubeek. (2020) Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: A systematic review. Journal of the American Academy of Dermatology 83:2, pages 412-424.
Crossref
Walter Masson, Martín Lobo & Graciela Molinero. (2020) Psoriasis and Cardiovascular Risk: A Comprehensive Review. Advances in Therapy 37:5, pages 2017-2033.
Crossref
Jing-Zhan Zhang, Yuan Ding, Fang Xiang, Shi-Rong Yu, De-Zhi Zhang, Meng-Meng Guan & Xiao-Jing Kang. (2020) Effectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials. Chinese Medical Journal 133:4, pages 444-451.
Crossref
Pengfei Chen, Xiubing Chen, Lei Lei, Yang Zhang, Jianjun Xiang, Jinxia Zhou & Jun Lv. (2020) The efficacy and safety of pioglitazone in psoriasis vulgaris. Medicine 99:32, pages e21549.
Crossref
Elena Godoy-Gijón, Carmen Meseguer-Yebra, Lucía Palacio-Aller, Diego Vicente Godoy-Rocati & Carlos Lahoz-Rallo. (2016) Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas. Clínica e Investigación en Arteriosclerosis 28:3, pages 143-153.
Crossref
Maddalena Napolitano, Matteo Megna & Giuseppe Monfrecola. (2015) Insulin Resistance and Skin Diseases. The Scientific World Journal 2015, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.